Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their consent to participate in the trial
- People who have been diagnosed with one of the following conditions: Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Glioblastoma (a type of brain tumour), certain cancers without a neurological disease (including lung cancer, breast cancer, ovarian cancer, melanoma, or thymoma), or rheumatoid arthritis
Who may not be able to join:
- People who do not give their consent to participate
- People whose neurological symptoms may be linked to a condition called paraneoplastic neurological syndrome or autoimmune encephalitis — these are conditions where the immune system or a cancer affects the nervous system (confirm with trial site)
- People who are under legal guardianship
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jerome Honnorat, Pr, Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes, Lyon, France
Phone: (33) 4 72 35 78 06
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Samples (blood dry and EDTA tube and optional cerebro-spinal-fluid)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.